Literature DB >> 8790234

Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home.

W S Aronow1.   

Abstract

OBJECTIVE: To investigate the prevalence of beta blocker use and calcium channel blocker use in older patients with prior myocardial infarction at the time of admission to a nursing home.
DESIGN: In a prospective study of 500 consecutive patients aged 60 years or older admitted to a nursing home, 202 (40%) had electrocardiographic evidence of Q-wave myocardial infarction at the time of admission. The prevalence of beta blocker use and of calcium channel blocker use was investigated in these 202 patients with previous myocardial infarction. The prevalence of beta blocker use and of calcium channel blocker use was also investigated in patients with myocardial infarction and abnormal left ventricular (LV) ejection fraction.
SETTING: A large long-term health care facility. PATIENTS: The patients included 344 women and 156 men, mean age 81 +/- 8 year (range 60 to 100).
MEASUREMENTS AND MAIN RESULTS: Of 500 patients, 202 (40%) had Q-wave myocardial infarction at the time of admission to the nursing home. Seventeen (8%) of these 202 patients with myocardial infarction were receiving beta blockers and 74 (37%) were receiving calcium channel blockers at the time of admission. Of 171 patients with myocardial infarction who had technically adequate measurements of LV ejection fraction, 59 (35%) had an abnormal LV ejection fraction (< 50%). Of the 59 patients with previous myocardial infarction and abnormal LV ejection fraction, four (7%) were receiving beta blockers and 19 (32%) were receiving calcium channel blockers at the time of admission.
CONCLUSIONS: Beta blockers are underutilized, and calcium channel blockers are overutilized in the treatment of older patients with a history of myocardial infarction at the time of admission to a nursing home.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790234     DOI: 10.1111/j.1532-5415.1996.tb02941.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

Review 1.  Challenges of prescribing low-dose drug therapy for older people.

Authors:  P A Rochon; J P Clark; J H Gurwitz
Journal:  CMAJ       Date:  1999-04-06       Impact factor: 8.262

2.  Patient-Important Adverse Events of β-blockers in Frail Older Adults after Acute Myocardial Infarction.

Authors:  Andrew R Zullo; Matthew Olean; Sarah D Berry; Yoojin Lee; Jennifer Tjia; Michael A Steinman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-07-12       Impact factor: 6.053

3.  Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.

Authors:  P A Rochon; G M Anderson; J V Tu; J P Clark; J H Gurwitz; J P Szalai; P Lau
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 4.  Under-utilisation of beta-blockers after acute myocardial infarction. Pharmacoeconomic implications.

Authors:  W D Bradford; J Chen; H M Krumholz
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

5.  Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents.

Authors:  Andrew R Zullo; Sadia Sharmin; Yoojin Lee; Lori A Daiello; Nishant R Shah; W John Boscardin; David D Dore; Sei J Lee; Michael A Steinman
Journal:  J Am Geriatr Soc       Date:  2017-10-17       Impact factor: 5.562

Review 6.  Postinfarction use of beta-blockers in elderly patients.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

7.  Beta-Blocker Use in U.S. Nursing Home Residents After Myocardial Infarction: A National Study.

Authors:  Andrew R Zullo; Yoojin Lee; Lori A Daiello; Vincent Mor; W John Boscardin; David D Dore; Yinghui Miao; Kathy Z Fung; Kiya D R Komaiko; Michael A Steinman
Journal:  J Am Geriatr Soc       Date:  2016-11-15       Impact factor: 5.562

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.